Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hanqing Wang
Observed name:
H. Wang
Institution:
Tianjin Medical University General Hospital
Observed institutions:
Tianjin University of Science and Technology,
Tianjin Medical University General Hospital,
Chinese PLA General Hospital,
ENN (China),
China National Center for Food Safety Risk Assessment,
Tianjin Medical University
show all 6
ORCID:
0009-0001-6800-5735
Observed ORCID:
0009-0001-6800-5735
OpenAlex ID:
A5077358353
MA11.06 A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies
2019
·
J. Zhang
, C. Zhou
, et al.
·
Journal of Thoracic Oncology
·
32
PDF
Overview of EXL-50 research progress
2025
·
Yuejiang Shi
, Yumin Wang
, et al.
·
Nuclear Fusion
·
18
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review
2025
·
Hao Zhang
, Wei Xia
, et al.
·
Frontiers in Oncology
·
6
The nomogram for the prediction of overall survival after surgery in patients in early‐stage NSCLC based on SEER database and external validation cohort
2023
·
Hao Zhang
, Jingtong Zeng
, et al.
·
Cancer Medicine
·
6
PDF
Rosemary Extract Mediated Lifespan Extension in Drosophila Melanogaster
2016
·
H.L. Wang
, Z.S. Zhang
, et al.
·
International Conference on Materials Chemistry and Environmental Protection (MEEP)
·
1
PDF
Development and Validation of a Prognostic Model Based on Postoperative Recurrence-Related Genes for Lung Adenocarcinoma
2026
·
Hao Zhang
, Yiwen Jian
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
6
Citation count:
63
H-index:
4
I10-index:
2
Year
Topic
Type